Nkarta, Inc. (NKTX)
2.26
+0.04
(+1.80%)
USD |
NASDAQ |
Oct 09, 16:00
2.26
0.00 (0.00%)
After-Hours: 20:00
Nkarta Net Income (Quarterly) : -40.37M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -40.37M |
| March 31, 2026 | -27.83M |
| December 31, 2025 | -27.41M |
| September 30, 2025 | -21.72M |
| June 30, 2025 | -22.98M |
| March 31, 2025 | -31.98M |
| December 31, 2024 | -25.94M |
| September 30, 2024 | -28.34M |
| June 30, 2024 | -24.99M |
| March 31, 2024 | -29.52M |
| December 31, 2023 | -27.75M |
| September 30, 2023 | -25.64M |
| June 30, 2023 | -33.29M |
| March 31, 2023 | -30.82M |
| December 31, 2022 | -32.58M |
| Date | Value |
|---|---|
| September 30, 2022 | -28.34M |
| June 30, 2022 | -26.92M |
| March 31, 2022 | -25.99M |
| December 31, 2021 | -22.81M |
| September 30, 2021 | -22.35M |
| June 30, 2021 | -21.54M |
| March 31, 2021 | -19.37M |
| December 31, 2020 | -17.90M |
| September 30, 2020 | -13.69M |
| June 30, 2020 | -51.07M |
| March 31, 2020 | -8.706M |
| December 31, 2019 | -10.49M |
| September 30, 2019 | -2.668M |
| June 30, 2019 | -4.838M |
| March 31, 2019 | -3.083M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 40.37M |
| EPS Diluted (Quarterly) | -0.5419 |
| Enterprise Value | 49.78M |
| Earnings Yield | -69.92% |
| Normalized Earnings Yield | -73.27 |